Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effientâ¢
- Details
- Category: Daiichi Sankyo

Bayer acquires exclusive rights to Bioton's insulin SciLin®
- Details
- Category: Bayer

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial
- Details
- Category: Amgen

AstraZeneca to Advance AZD3480 in ADHD
- Details
- Category: AstraZeneca

Bayer submits first-in-class estradiol-based oral contraceptive for approval in the US
- Details
- Category: Bayer

Lundbeck strengthens its research capabilities by acquiring ground-breaking Danish technologies
- Details
- Category: Lundbeck

Top 10 Tips for Staying Healthy When Money is Tight
- Details
- Category: Eli Lilly and Company

More Pharma News ...
- Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
- GSK further extends its product portfolio in the Middle East and North Africa
- Lu AA24530 shows positive results in major depressive disorder phase II study
- Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
- Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
- Bayer files patent infringement lawsuit against Teva
- IRESSA (Gefitinib) Receives Marketing Authorisation in Europe